US Patent Issued to Keros Therapeutics on Dec. 30 for "Methods of using ALK2 inhibitors" (Massachusetts Inventors)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,508,262, issued on Dec. 30, was assigned to Keros Therapeutics Inc. (Lexington, Mass.).

"Methods of using ALK2 inhibitors" was invented by Jasbir S. Seehra (Lexington, Mass.), Jennifer Lachey (Lincoln, Mass.) and Elissa Furutani (Belmont, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to methods of treating multiple osteochondroma and anemia resulting from iron imbalance using small molecule ALK2 inhibitors."

The patent was filed on April 30, 2021, under Application No. 17/246,577.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p...